The Gross Margin of Beijing Konruns Pharmaceutical Co Ltd (603590.SS) is 89.92%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-12-31 | 89.92% |
| 2024-12-31 | 89.55% |
| 2023-12-31 | 89.02% |
| 2022-12-31 | 85.39% |
| 2021-12-31 | 86.94% |
| 2020-12-31 | 92.68% |
| 2019-12-31 | 94.59% |
| 2018-12-31 | 95.11% |
| 2017-12-31 | 92.38% |
| 2016-12-31 | 88.97% |